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Abstract
Marek’s Disease Virus (MDV) is an avian alpha-herpesvirus that only spreads from cell-to-cell in cell culture. While its cell-to-
cell spread has been shown to be dependent on actin filament dynamics, the mechanisms regulating this spread remain
largely unknown. Using a recombinant BAC20 virus expressing an EGFPVP22 tegument protein, we found that the actin
cytoskeleton arrangements and cell-cell contacts differ in the center and periphery of MDV infection plaques, with cells in
the latter areas showing stress fibers and rare cellular projections. Using specific inhibitors and activators, we determined
that Rho-ROCK pathway, known to regulate stress fiber formation, and Rac-PAK, known to promote lamellipodia formation
and destabilize stress fibers, had strong contrasting effects on MDV cell-to-cell spread in primary chicken embryo skin cells
(CESCs). Inhibition of Rho and its ROCKs effectors led to reduced plaque sizes whereas inhibition of Rac or its group I-PAKs
effectors had the adverse effect. Importantly, we observed that the shape of MDV plaques is related to the semi-ordered
arrangement of the elongated cells, at the monolayer level in the vicinity of the plaques. Inhibition of Rho-ROCK signaling
also resulted in a perturbation of the cell arrangement and a rounding of plaques. These opposing effects of Rho and Rac
pathways in MDV cell-to-cell spread were validated for two parental MDV recombinant viruses with different ex vivo spread
efficiencies. Finally, we demonstrated that Rho/Rac pathways have opposing effects on the accumulation of N-cadherin at
cell-cell contact regions between CESCs, and defined these contacts as adherens junctions. Considering the importance of
adherens junctions in HSV-1 cell-to-cell spread in some cell types, this result makes of adherens junctions maintenance one
potential and attractive hypothesis to explain the Rho/Rac effects on MDV cell-to-cell spread. Our study provides the first
evidence that MDV cell-to-cell spread is regulated by Rho/Rac signaling.
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Introduction
Marek’s disease virus (MDV), also referred to as Gallid herpesvirus
2, is the causative agent of Marek’s Disease (MD) in chickens, a
multifaceted disease most widely recognized by the induction of a
malignant T-cell lymphoma. MDV is a type-species of the
Mardivirus genus (Marek’s disease-like viruses) within the Alpha-
herpesvirinae subfamily of the Herpesviridae family. MDV replicates
exclusively in avian cells, and efficiently to date only when they are
explanted [1]. In these in vitro systems, MDV remains strictly cell
associated without infectious enveloped particles being detectable
in the supernatant and/or at the external cell surface [2,3,4].
Upon infection of the chicken host, MDV is likely transmitted in a
cell-to-cell manner (e.g. between lymphocytes or from lymphocytes
to skin), as no free virus can be detected in the plasma of infected
birds [1]. MDV belongs to the rare category of viruses that does
not spread in cell culture through the cell-free aqueous environ-
ment but only in the context of cell contacts between infected cells
and naı¨ve cells, a process termed ‘‘cell-to-cell spread’’. While the
detailed mechanisms of MDV cell-to-cell spread are still largely
unknown, their elucidation would enhance our understanding of
MDV biology.
To spread from cell-to-cell, viruses use either physiological cell-
to-cell contacts and/or virus-driven contacts, that are permanent
or transient (reviewed in [5,6]). Filopodia, unique or multiple
branched plasma membrane extensions, nanotubes, viral synapses
and adherens junctions have been implicated in these processes
[7,8,9,10,11,12,13]. For herpesviruses, depending on the in vitro
infection system, various cell contact structures and routes have
been described to be relevant for cell-to-cell spread. Both
Pseudorabies Virus (PRV) and Herpes Simplex Virus 1 (HSV-1)
were shown to induce long actin filaments-containing projections
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[8,14,15] and to traffic within it [8] or at their surface [15],
respectively. Murine gamma-herpesvirus-68 (MHV-68) was shown
to induce the outgrowth of long, branched, RhoA-dependent,
actin-based plasma membrane fronds driven by the cytoplasmic
tail of the viral gp48 glycoprotein [9], a protein which was also
shown to promote viral spread [16]. For HSV-1, the virological
synapse was shown to facilitate its entry into T-cells [7]. Finally,
adherens junctions (AJs) were demonstrated to be a preferred
route of HSV-1 dissemination because nascent HSV-1 virions are
specifically sorted in this area in polarized HEC1A and MDBK
epithelial cells [10]. In addition, the nectin-1, a component of AJs,
was identified as a receptor for HSV-1 and HSV-2 glycoprotein D
[17,18]. All of these structures are dependent on filamentous actin
(F-actin) for their formation and/or stability and some are directly
modulated by one or several RhoGTPases signaling pathways.
F-actin is organized in three major structures in fibroblastic
cells: stress fibers, lamellipodia, and filopodia [19]. All three
structures are dynamic and their prevalence varies according to
the cell type, physiology and environment [20]. The stress fibers/
lamellipodia/filopodia balance is regulated by extracellular
stimuli, including soluble factors and mechanical tensions, and
involves the most studied RhoGTPases family members, Rho, Rac
and Cdc42 (reviewed in [19,21,22]. In fibroblasts, RhoA
activation promotes the formation of stress fibers, the maturation
of focal complexes into focal adhesion and the maintenance of AJs
[23,24]; Rac1 activation yields to lamellipodia, dorsal ruffles
formation, AJs initiation and formation of focal complexes [23,25].
The activation of Cdc42 leads to the extension of filopodia [26].
RhoA, Rac1 and Cdc42, have several effectors, usually distinct,
but sometimes common like p21-activated kinases (PAKs) for
Rac1 and Cdc42, and mDia for Rho proteins and Cdc42 [27,28].
The three Rho isoforms (A, B and C) have several common
effectors as mDia and Rho-kinase (ROCK) 1 and 2 [29], which
are both essential for stress fibers formation. mDia proteins
catalyze the nucleation and polymerization of unbranched actin
filaments for stress fibers and also for filopodia formation [30].
ROCK proteins promote and maintain stress fibers assembly as
actomyosin contraction by phosphorylating both myosin light
chain (MLC) and MLC phosphatase [31]. In contrast to ROCKs,
activated PAK1 phosphorylates the myosin light chain kinase
(MLCK), resulting in decreased MLCK activity and reduced
actomyosin assembly [32].
For MDV, the contribution of actin filaments to viral cell-to-cell
spread has thus far only been reported by Schumacher et al. [33].
The authors found that cytochalasin D (CytD) treatment, blocking
actin polymerization, resulted in a reduction in the size and
number of viral plaques. Given this result, our goal was to study
whether actin organization and possibly actin dependent cell-cell
contact, in relationship with RhoGTPases signaling, influence
MDV cell-to-cell spread. For that, we used cells shown to be highly
permissive for MDV replication, primary chicken embryo skin
cells (CESCs) and measured MDV plaque size after modulating F-
actin and Rho/Rac signaling pathways with different pharmaco-
logical agents. Our data show that MDV cell-to-cell spread is
regulated in opposed manner by Rho/Rac signaling pathways and
that efficient spread requires ROCKs signaling including myosin
II activity.
Results
Actin filaments and their dynamics are important for
MDV spread
Our MDV cell-to-cell spread model employs the co-culture of a
CESCs confluent layer with GFP+-sorted infected cells at very low
multiplicity of infection (moi) in order to get individualized
plaques. The virus used was a BAC20-EGFP reporter expressing
an EGFPVP22 protein [34]. MDV cell-to-cell spread was
quantified by plaque size measurement, at 4 days post-infection
(pi). Initially, we verified, using our MDV cell-to-cell spread assay,
the effect on MDV spread of two agents that modulate F-actin
formation. CytD is a fungal metabolite which prevents polymer-
ization by reversibly binding to the barbed ends of F-actin and
globular actin [35] while the jasplakinolide (Jaspl) stabilizes F-actin
and induces actin polymerization [36]. We determined the most
active and less-toxic concentration of these drugs on a dense
monolayer of CESCs, monitoring the presence of actin filaments
and the cell morphology. For each maximum drug concentration
used, the cell viability was evaluated, after a 4-day treatment
(Fig. 1).
The maximum tolerated concentration of CytD (100 nM)
induced an incomplete disassembly of stress fibers (Fig. 1B), in
comparison with untreated cells (Fig. 1A) and a 23% decrease in
cell viability (Fig. 1D). Higher concentrations of CytD were
incompatible with our spread assay because the CESCs rounded-
up and detached from the plastic dish surface. After a 4-day
treatment of CESCs with CytD, MDV dissemination was dose-
dependently reduced. At 100 nM of CytD, MDV plaques were
69% smaller than those on untreated cells (Fig 1B), which is in
good agreement with the previous report of Schumacher and
collaborators [33]. The addition of Jaspl on CESCs preserved
stress fibers and did not affect cell viability but resulted in the
formation of cytoplasmic actin aggregates (Fig. 1C), as was
previously reported for mammalian cells [37,38]. Jaspl at 100 nM
reduced MDV spread by 31% compared to untreated cells.
Therefore CytD and Jaspl reduced MDV spread in our cell system
and we confirmed that actin dynamic is important for MDV cell-
to-cell spread.
Actin cytoskeleton organization and cell-cell contacts are
highly re-arranged in the center of MDV infection
plaques but not in the periphery
MDV infection with the BAC20 strain in CEFs was described to
destroy stress fibers in 70% of infected cells [33], when infected
cells were reseeded sparsely. It appeared therefore important to us
to analyze the actin cytoskeleton rearrangement directly at the
level of an infection plaque, especially at its periphery where MDV
cell-to-cell spread occurs. At high density, non-infected cells are
well spread with a fusiform morphology, pronounced stress fibers
mostly oriented in the long cell axis and cell-cell contacts, as
expected for a cell preparation enriched in primary chicken skin
fibroblasts (Fig. 2, A1–A2). At high density, cells often partially
overlay especially at their extremities. Observation of BAC20-
EGFP-infected cells localized in the center of a 4 day-old infection
plaque showed that they are all devoid of stress fibers with reduced
cell-cell contacts. Their morphology was also changed as they
became round (Fig. 2, B1–B3). In contrast, infected cells localized
at the peripheral rim of the viral plaque still conserved a
substantial amount of stress fibers (Fig. 2, C1–D3) and cell-cell
contacts. The morphology of these cells did not show pronounced
changes compared to uninfected cells and we did not frequently
observe the induction of long cell extensions from infected cells
(not shown). Careful observations of peripheral infected cells also
showed that their stress fibers are aligned with those of uninfected
cells (Fig. 2, C1–D3). At the contact between two cells having their
stress fibers in the same axis, the phalloidin staining was more
pronounced with a zipper aspect shape, reminiscent of AJs, the
only physiological cell-cell contact known in fibroblasts. Indeed, in
such cell type, stress fibers arrive perpendicular to the cell-cell
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contacts where they anchor to AJs [24,39,40]. This feature could
also be observed between two infected cells expressing the
EGFPVP22 (Fig. 2, D1–D3). These results showed that stress
fibers, the elongated shape of the cells and cell-cell contacts are
maintained in infected cells at the periphery of viral plaques but
not in their center. This also showed that stress fibers and cell-cell
contacts are present until a late stage of infection (i.e. cells
expressing EGFPVP22 tegument protein). This suggested that
stress fibers and cell-cell junctions are destabilized only when cells
are infected for a prolonged period of time and that spread could
probably precede these profound cell changes.
The inhibition of Rho and ROCK signaling decreases MDV
spread
As Rho signaling pathway is well known to regulate stress fibers
formation and maintenance, we next studied the impact of this
pathway on MDV spread, by blocking or activating Rho protein
activities. The transfection rate of primary CESCs barely
exceeding 20–25%, we could not undertake approaches for which
the success depends on high transfection rates of the cell layer, like
RNAi or the overexpression of a dominant active or negative
protein through an expression vector. We therefore use either
drugs, receptor agonists or a TAT-purified protein. The TAT-C3
transferase is an ADP-ribosylating protein of Clostridium botulinum
that inactivates the three different Rho proteins (A, B, and C)
through direct covalent binding of an ADP-ribose to the
asparagine 41 site [41,42]. This purified protein system presents
the advantage to target all cells [43] and to allow a control of the
inhibitor quantity used, in contrast to the over-expression of a
dominant negative mutant. The addition of 16 mg/mL of purified
TAT-C3 transferase to the culture media of CESCs induced an
incomplete stress fiber breakdown with cells remaining well spread
(Fig. 3A). This phenotype, although moderate, indicated an effect
on Rho, and showed indirectly that TAT-C3 transferase is able to
penetrate through cell membrane to exert its biological activities in
CESCs (Fig. 3A) as already described [43]. A more robust
phenotype (like after microinjection) with a complete loss of stress
fibers, a collapse of cell body and a decrease of cell spread would
not have been compatible with our virus assay [44,45]. In our
conditions, MDV plaque sizes were decreased by 47% (Fig. 3A)
and the cell viability was decreased by 23% (Fig. 3G), albeit the
cell confluency was not altered. It should be noticed that TAT-C3
experiments were performed on 24-well plates whereas other
experiments were done on 6-well plates and that for unknown
reason the BAC20-EGFP plaque size was reproducibly approx-
imately two times smaller in the former. Treatment of cells with
16 mg/mL of lysophosphatidic acid (LPA), a phospholipid known
to activate Rho proteins activity through the LPA receptors,
increased the size of plaques, up to 83% (Fig. 3B) without altering
the cell viability (Fig. 3G).
The two major effectors of Rho proteins are ROCKs and Dia
involved in actomyosin contraction and actin filament polymer-
ization, respectively [27]. Due to the abundance of stress fibers in
CESCs cell monolayers under normal conditions, and the lack of
tools for studying chicken Dia, we examined solely the involve-
ment of ROCK proteins. To this end, we used the Y-27632,
reported to specifically inhibit the kinase activity of ROCK 1 and
2, without inhibiting those of PAKs or MLCK [46]. As expected,
CESCs treatment with 80 mM of Y-27632 for 4 days led to a loss
of stress fibers (Fig. 3C). This treatment also led to cell extensions
induction and gaps between cells suggesting that cell-cell junctions
are disrupted as previously reported [24]. Y-27632 treatment also
Figure 1. Modulators of actin polymerization decrease MDV cell-to-cell spread. CESCs monolayers were infected or not with the BAC20-
EGFP for 6 hrs, and then treated for 4 days at the indicated drug concentration. (A) Upper panel, F-actin staining (AlexaFluor594-Phalloidin) in non-
infected cells. Lower panel, representative example of a BAC20-EGFP plaque which area was measured in mm2. Bar, 200 mm. (B) Effect of CytD on actin
polymerization and MDV cell-to-cell spread. Upper panel, F-actin staining of non-infected CESCs treated with 100 nM of CytD. Lower Panel, the graph
shows a quantitative analysis of fifty plaques size in one of three representative experiments. Error bars represent the SEM. Percentages on graphs
indicate the decrease (2) in plaques size compared to the untreated cells (***, p,0.001). (C) Effect of Jaspl. F-actin staining and plaques size are
shown, as in (B). (D) The relative cell viability after a 4-day treatment with each drug at the highest concentration used. Values were normalized as
compared to untreated cells. Error bars represent the SEM. Percentages on the graph indicate the decrease (2) in viability. The dashed line represents
the acceptable CESCs viability limit (0.75) that was set in this study. For F-actin detection, bars, 20 mm.
doi:10.1371/journal.pone.0044072.g001
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resulted in decreased MDV plaque sizes in a dose-dependent
manner with a 65% reduction at the highest concentration used
(Fig. 3C). In presence of 80 mM of Y-27632, a reduction of 22% in
CESCs viability was measured (Fig. 3G). To confirm ROCK
contribution, we used a second ROCK inhibitor, the Fasudil (also
named HA 1077). This compound was reported to inhibit the
kinase activity of ROCKs as well as other kinases in particular at
high concentrations [47,48]. This molecule, like Y-27632, induced
breakdown of stress fibers and of cell-cell junctions as well as cell
shape changes (Fig. 3D). The Fasudil also reduced MDV plaques
size in a dose-dependent manner with a 48% reduction at the
highest concentration used of 60 mM. At this dose, no reduction in
CESCs viability was recorded. The viability was even increased
compared to untreated conditions suggesting a stimulation of the
cell division (Fig. 3G). Therefore both ROCK inhibitors decreased
MDV in a dose dependant manner. In order to evaluate the
possible off-target contribution of ROCK inhibitors in the MDV
spread especially at high doses, we next analyze the phosphory-
lation of a major ROCK substrate, the Myosin Light Chain
(MLC) in presence of Y-27632 and Fasudil in CESCs. Monolayers
of non-infected CESCs treated with different doses of Y-27632 or
Fasudil for 4 days were lyzed and the lysates analyzed by Western
blotting using an antibody which recognize phosphorylated MLC.
Despite high background with the anti-phospho-MLC on chicken
cell lysates, a quasi total inhibition of MLC phosphorylation was
observed with Y-27632 between 20 and 40 mM and with Fasudil
between 30 and 45 mM (Fig. 3E). These concentrations are in
accordance with the ones previously used in rat and chicken
embryonic fibroblasts [46,49]. This result indicates that the
supplemental decrease of MDV spread observed at upper dose
of Y-27632 and Fasudil are probably due to off-targets effects. All
together, these results show that MDV spread is dependent on
ROCKs activity.
The Rho-ROCK pathway promotes actomyosin II contraction
via the direct phosphorylation of MLC phosphatase and MLC via
ROCKs [31]. We therefore investigated the role of actomyosin II
contraction on MDV cell-to-cell spread. For that, we used
blebbistatin (Bleb), a specific inhibitor of the non muscular myosin
II (NMII) ATPase activity [50]. Chicken cells treated with 50 mM
of Bleb showed a partial disorganization of stress fibers (Fig. 3F) as
well as small gaps between cells suggesting a loosening of cell-cell
junctions. This cell phenotype indicated an action on avian cells
similar to the one described in mammalian cells [24,51].
Treatment of the CESCs monolayer with 50 mM of Bleb yielded
a 64% reduction of MDV spread (Fig. 3F) with a cell viability
reduction of 20% (Fig. 3G). Thus, Rho-ROCK activity and
actomyosin II contraction, a final effector of this signaling pathway
appears to be crucial for MDV cell-to-cell spread on primary
CESCs.
Rac-PAK signaling have an inhibitory effect on MDV cell-
to-cell spread in CESCs
Given the apparently importance of Rho-ROCK signaling in
MDV cell-to-cell spread, we next wanted to confirm these results
by analyzing the effect of Rac-PAK signaling. Indeed, Rac is
known to counteract stress fibers formation through its inhibitory
Figure 2. Actin cytoskeleton is rearranged in the center of MDV infection plaques but not in periphery. Immunofluorescence
microscopy of non infected cells (column A) and BAC20-EGFP infected cells, after 4 days of growth on the CESCs monolayer are shown, in the center
of a representative infection plaque (column B), or in the periphery (columns C–D). F-actin was stained with AlexaFluor594-Phalloidin (red) (line 2) and
DNA with Hoechst 33342 (blue) (B1–D1). Infected cells express the EGFPVP22 protein (green) (line 3). Asterisks show infected cells still possessing
stress fibers. Arrowheads show infected cells which present connections between their stress fibers and those of neighboring infected or uninfected
cells. Note that pictures in columns B and C are a superposition of 6 z stacks of 0.250 mm each, whereas pictures A and D correspond to a unique cut.
All scale bars, 20 mm.
doi:10.1371/journal.pone.0044072.g002
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Figure 3. Inhibition of the Rho-ROCK signaling pathway decreases MDV cell-to-cell spread. (A) Effect of TAT-C3 transferase, an inhibitor
of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 mg/mL of TAT-C3 transferase (bar, 20 mm). Lower panel, a picture
of a representative BAC20-EGFP infection plaque obtained with 16 mg/mL of TAT-C3 transferase (bar, 200 mm). Right panel, the graph shows a
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action on MLCK via PAKs in many systems, including primary
chicken embryo fibroblasts [25,52,53]. Rac1 involvement was
examined using two agents: the NSC23766, a molecule which was
described to specifically inhibit Rac1 by preventing the binding
between Rac1 and its activator proteins, the guanosine nucleotide
exchange factors [54] and sphingosine-1-phosphate (S1P), a lipid
that activates Rac1 through S1P-receptor signaling [55]. A
treatment of CESCs with 60 mM of NSC23766 during the
MDV spread assay resulted in a 40% increase of MDV plaque
sizes (Fig. 4A). Conversely, MDV spread was decreased by 54%
when the cell monolayer was treated with 8 mM of S1P (Fig. 4B).
S1P treatment reduced cell viability by 6% while treatment with
NSC23766 reduced it by up to 25%, at the highest concentrations
(Fig. 4D). Despite a reduction in cell viability, the cell monolayer
remained confluent after NSC23766 treatment and MDV spread
was increased.
Having shown a negative effect of Rac signaling on MDV
dissemination, we then tested the effect of PAKs, downstream
effectors of Rac1. To this end we used IPA-3, a specific inhibitor of
group I-PAKs, which does not affect ROCKs or MAP kinase
proteins [56]. IPA-3 activity was controlled on the basis of
lamellipodia disappearance in CESCs plated at low density
(Fig. 4E). An IPA-3 concentration of 10 mM specifically increased
the MDV plaque size by 36% (Fig. 4C) while cell viability
remained virtually unaffected (Fig. 4D).
All together, these results show that MDV dissemination is
negatively regulated by Rac1 stimulation involving group-I PAKs
effectors signaling and is promoted by Rac1 inhibition.
LPA and S1P effects on MDV spread are totally or partially
mediated by Rho and Rac signaling
In order to investigate if LPA and S1P may influence MDV
spread through other signaling pathways than Rho-ROCK and
Rac-PAK respectively, we examined MDV spread in presence of
these activators in combination with a selective inhibitor acting
downstream of each signaling pathway. We first measured MDV
plaques size in presence of 16 mg/mL of LPA in combination with
two concentrations of Y-27632 (20, 40 mM), inhibiting partially or
totally MLC phosphorylation and not modifying cell viability. In
these conditions, MDV spread was not significantly different from
the one measured with Y-27632 alone at the same concentration
(Fig. 5A). This suggests that LPA effect on MDV spread is totally
counteracted by Y-27632 and is preferentially mediated by
ROCKs. We next examined MDV plaque size, after simultaneous
treatment with S1P at 8 mM and IPA-3 inhibitor (5 or 10 mM).
The use of 10 mM of IPA-3 in presence of 8 mM of S1P restored
MDV plaque size similar to untreated condition (Fig. 5B).
Nevertheless, MDV spread did not reach the level obtained in
presence of IPA-3 alone (Fig. 5B). This result indicates that S1P
effect is partially counteracted with type I-PAKs inhibition and
can be interpreted in three manners: (i) either 8 mM S1P activates
more PAKs molecules via Rac than IPA-3 at 10 mM is able to
inhibit (ii) S1P may activate PAKs isoforms not inhibited by IPA-3,
(iii) or S1P activates another pathway than Rac-PAK, having a
negative effect on MDV spread. All three hypotheses are plausible
as (i) for a fixed concentration of S1P, the plaque size responds to
IPA-3 in a dose-dependent manner, (ii) IPA-3 only inhibits type I-
PAKs and we cannot exclude a role for other PAKs isoforms
activated by S1P [56] and (iii) S1P can also signal through other
pathways, like PI3K/akt and Ras/Erk, which may affect MDV
spread independently of PAKs [57].
MDV plaques are shaped in relation with the cell shape
and the semi-ordered cell arrangement in its micro-
environment
In order to find to which cell structure linked to stress fibers
MDV cell-to-cell spread could be related, we carefully inspected
the BAC20-EGFP-infected cell monolayers by phase contrast
microscopy (Fig. 6A) and by fluorescence microscopy after
phalloidin-labelling of F-actin (not shown). Mock-infected cells
and cells outside of viral plaques are tightly packed, joined,
spindle-shaped with their elongated body generally in line with the
one of neighbouring cells, in a semi-ordered manner highlighted
with white dashed lines in Fig. 6A. Moreover in these cells, the
central stress fibers are generally oriented with the long axis of the
elongated body and therefore in relation with the cell shape
(Fig. 2A). In normal growth conditions, the MDV plaques were
pleiomorphic, irregularly shaped, appearing to follow the pattern
of surrounding semi-ordered cells (Fig. 6A, lines a and b). It is
noticeable that when several plaques are next to each other, they
may show a parallel orientation (Fig. 6A, line b). This observation
shows that MDV plaques shape is related to the cell shape and
arrangement of uninfected surrounding cells in its environment.
Inhibition of Rho-ROCK signaling results in plaques
morphology change in addition to plaques size
reduction
We next explore if the plaque morphology was modified in
presence of molecules modulating Rho/Rac pathways. In the
presence of 16 mg/mL of LPA or of 10 mM of IPA-3 (Fig. 6A,
lines c and d) as well as with NSC23766 (data not shown), the
conditions in which stress fibers remained intact as well as cell
shape and cell arrangement at the monolayer level, the overall
plaques morphology was pleiomorphic, like in control condition.
Interestingly, when actin-depolymerizing agents were used,
including TAT-C3 transferase at 16 mg/mL (Fig. 6, line e), Y-
27632 at 20 mM or 80 mM (Fig. 6, lines f and g) and Bleb at
50 mM (data not shown), stress fibers and pattern of semi-ordered
cells disappeared. In these conditions, MDV plaques adopted a
more rounded shape, in addition to displaying a reduced size. The
morphological differences in plaques shape were supported by an
analysis of the ratio between plaque length and plaque width.
These ratios were closer to 1 with TAT-C3 transferase, Y-27632
and Bleb compared to untreated conditions, what was expected for
more rounded plaques (Fig. 6B). In contrast, no difference in these
quantitative analysis of plaques size in one of two to three representative experiments (***, p,0.001). The error bars represent the SEM of 50 plaques
size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***,
p,0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A
(***, p,0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel),
as in A (*, 0.1,p,0.5; ***, p,0.001). (E) After a 4-day treatment with the indicated concentrations of Y-27632 (left) or Fasudil (right), MLC
phosphorylation was monitored by Western blotting with an anti-phospho-MLC (Thr18/Ser19) antibody followed by an alkaline phosphatase-labeled
secondary antibody. An anti-GAPDH antibody was used to control the amount of proteins in each lysate. (F) Effect of blebbistatin, an inhibitor of
NMIIA ATPase activity, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p,0.001). (E) One of two
representative experiments showing the relative cell viability after a 4-day treatment with the highest concentration of TAT-C3 transferase, LPA, Y-
27632, Fasudil and blebbistatin are presented. Values were measured and normalized as above. Error bars represent the SEM.
doi:10.1371/journal.pone.0044072.g003
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ratios was observed with LPA at 16 mg/ml or IPA-3 at 5 or 10 mM
(Fig. 6B), conditions in which the plaques shapes remained
pleiomorphic with more elongated and variable forms.
In conclusion, these results indicate that the semi-ordered
arrangement of the cells has a marked influence on the shape of
MDV plaques. Moreover, when the semi-ordered arrangement of
the cells was abrogated by stress fibers depolymerization, MDV
plaques became more circular and isotropic. These observations
suggest that the MDV infection may progress preferentially from
one cell to another in plaques periphery, when their stress fibers
are matched in a row.
Rho/Rac signaling pathways involvement in MDV spread
is independent of the viral strain used
So far we presented spread data obtained with a recombinant
MDV reporter having the N-terminus of VP22 fused to EGFP that
is partially impaired in its spread efficacy compared to the parental
Figure 4. MDV cell-to-cell spread is enhanced upon inhibition of the Rac signaling pathway. Monolayers of CESCs were infected or not
with the BAC20-EGFP for 6 hrs, and then treated for 4 days with the indicated concentrations of inhibitors or activator. (A) The effect of a Rac
inhibitor, NSC23766, on MDV cell-to-cell spread. Upper panel, F-actin staining of non-infected CESCs treated with 60 mM of NSC23766 (bar, 20 mm).
Middle panel, a representative BAC20-EGFP infection plaque obtained following treatment with 60 mM of NSC23766 (bar, 200 mm). Lower panel, the
graph shows a quantitative analysis of plaques size in one of three representative experiments. Percentages on graphs indicate the increase (+) in
plaques size compared to the untreated cells (***, p,0.001). The error bars represent the SEM of 50 plaques size. (B) The effect of S1P, a Rac1
activator, on F-actin (upper panel), on plaques shape (middle panel) and plaques size (lower panel), as in A (***, p,0.001). (C) Effect of IPA-3, an
inhibitor of group I-PAKs, on F-actin (upper panel), plaques shape (middle panel) and plaques size (lower panel), as in A (***, p,0.001). (D) One of
three representative experiments showing the relative cell viability after a 4-day treatment with the highest concentration of NSC23766, S1P and IPA-
3 are presented. Values were measured and normalized as presented above. Error bars represent the SEM. (E) Control of IPA-3 on CESCs. F-actin was
stained on sparsely seeded CESCs, untreated (left), or treated for 2 hrs with 10 mM of IPA-3 (right). For each condition, a two fold magnification of the
box is shown next to the lower magnification. Solid arrowheads point to filopodia while open arrowheads point to lamellipodia. All bars, 20 mm.
doi:10.1371/journal.pone.0044072.g004
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BAC20 virus. In order to verify that our previous observations
were not specific of this mutant and to discard a potential
association with VP22, we next assayed two parental recombinant
viruses: the non-pathogenic BAC20 and the highly virulent
recombinant BAC RB-1B strain [58]. It should be indicated here
that the BAC RB-1B, which is highly virulent in chickens,
produces smaller plaques than the non-pathogenic BAC20,
adapted to cell culture. The plaques size obtained with the BAC
RB-1B are in the same range than those obtained with the
BAC20-EGFP on CESCs. Spread of both parental viruses was
dose-dependently diminished when TAT-C3 transferase or Y-
27632 was added to the CESCs culture media (Fig. 7). Moreover,
the presence of NSC23766 led to an increased dissemination for
these two viruses, as previously seen with the BAC20-EGFP.
Lastly, the same influence of the semi-ordered cell arrangement on
plaques shape was observed with the BAC RB-1B and BAC20
viruses (data not shown).
Figure 5. LPA and S1P effects on MDV cell-to-cell spread are mediated through Rho-ROCK and Rac-PAK respectively. Monolayers of
CESCs were infected or not with the BAC20-EGFP for 6 hrs, and then treated for 4 days at the indicated molecule concentrations. (A) Specificity of the
LPA effect on MDV spread through the Rho-ROCK pathway. In the left panel, a representative picture of both F-actin staining of non-infected CESCs
(bar, 20 mm) and BAC20-EGFP infection plaque (bar, 200 mm) obtained after each double treatment. In the right panel, the graph shows a quantitative
analysis of plaques size in one representative experiment over two (ns, non significant; ***, p,0.001). The number at the top of each histogram
indicates the ratio between plaques size after treatment compared to the untreated condition. The error bars represent the SEM of 50 plaques size.
(B) Specificity of the S1P effect on MDV spread through the Rac-PAK pathway. The effect of the indicated double treatments on F-actin and on the
plaques size are presented like in A.
doi:10.1371/journal.pone.0044072.g005
MDV Cell-to-Cell Spread and Rho/Rac Pathways
PLOS ONE | www.plosone.org 8 August 2012 | Volume 7 | Issue 8 | e44072
Figure 6. Inhibition of Rho-ROCK signaling results also in a rounding of MDV plaques. (A) Typical images of BAC20-EGFP infection plaques
4 days post-infection without treatment (lines a and b), or in the presence of 16 mg/mL of LPA (line c), 10 mM of IPA-3 (line d), 16 mg/mL of TAT-C3
transferase (line e), 20 mM of Y-27632 (line f) or 80 mM of Y-27632 (line g) are shown. For each condition, the cell monolayer was photographed in
white light with phase contrast and infected cells in fluorescence with EGFPVP22. Cell monolayer (greyscale) and infection plaques (green) are shown
merged (column 1). In some conditions, a semi-ordered cell arrangement is visible in uninfected region of the cell monolayer with phase contrast.
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These data clearly show that the spread of the two parental
viruses is affected in the same manner by Rho/Rac pathways
manipulation than the BAC20-EGFP, independently of the strain
origin and of the original spread efficiency. They also demonstrate
that Rho/Rac signaling pathways regulates MDV independently
of its tag fused to VP22.
Rho-ROCK pathway inhibition and the concomitant
stress fiber depolymerization are associated with the
disappearance of adherens junctions in CESCs
We next examined the AJs presence and stability in CESCs
after Rho/Rac modulations for several reasons: (i) the presence of
cell-cell junctions reminiscent of AJs in our cell layer between
infected and non-infected cells (Fig. 2), (ii) the anchorage of stress
fibers ends to AJs in fibroblasts [24,39,40], (iii) the previous
description of a role for AJs into HSV-1 cell-to-cell spread in
polarized epithelial cells [10] and (iv) the important role of Rho
signaling in the formation and/or maintenance of AJs in
mammalian myoblasts or fibroblasts [24,59,60]. The cell junctions
were re-examined at high magnification after phalloidin staining of
monolayers of non-infected cells treated for 4 days with a panel of
molecules affecting the Rho/Rac pathways. The zipper aspect
shape at the cell junctions was visible under all conditions where
MDV spread was not modified (untreated cells) or increased (LPA,
NSC23766) (Fig. 2A, 3B and 4A). It is noteworthy that the cell
junctions appeared more pronounced after treatment with
NSC23766 or LPA, two conditions under which MDV spread
was increased (Fig. 3B and 4A). In contrast, the zipper aspect
shape at the cell contacts was partially or totally lost in conditions
where MDV cell-to-cell spread was decreased, following treatment
with TAT-C3 transferase, Y-27632, Fasudil or Bleb (Fig. 3A, 3C,
3D and 3F).
In order to better characterize cell junctions in CESCs, a
confluent CESCs monolayer was stained for F-actin and for N-
cadherin, a specific component of AJs in fibroblasts and myoblasts
[59,61,62]. We observed that under normal conditions, N-
cadherin was localized exclusively at cell contacts between two
aligned cells as expected for an AJs marker in such cells (Fig. 8,
A2). This staining appeared fragmented as dots between two cells
and located preferentially when their stress fibers are in line with
each other at both ends of these junctions (Fig. 8, A3–A4). We next
studied the N-cadherin and F-actin stainings in cells treated with
agents, which act on the Rho/Rac pathways and thereby
modulate MDV spread. With 16 mg/mL of LPA, the N-cadherin
staining was more evenly distributed at the cell periphery and less
discontinuously (Fig. 8, B2–B4). In addition, the stress fibers
appeared thicker and less parallel than under the control
conditions (Fig. 8, A1 and B1). In the presence of 40 mM of Y-
27632, the N-cadherin staining almost disappeared as well as the
central stress fibers (Fig. 8, C1–C4). Finally with 40 mM of
NSC23766, the N-cadherin preferentially localized when their
stress fibers are in line with each other at both ends of these
junctions, like under control conditions (Fig. 8, D1–D4). The
major difference is that the N-cadherin staining at the cells
junctions looked continuous and not fragmented. Medium doses of
Y-27632 and NSC23766 were used in this experiment as they give
good ratio of MDV spread on cell viability. Taken together, these
results show that Rho/Rac pathways modify the N-cadherin
presence at the cell-cell junction of CESCs in an opposite manner.
This cell arrangement is indicated with white dashed lines on the pictures (column 2). Bars, 200 mm. (B) The graph shows a quantitative analysis of the
ratio between plaque length and plaque width under the indicated growth conditions. A ratio of 1 corresponds to a perfect circle. The ratio will be
increased by the degree to which the plaque is elongated. The median value for each experimental group is indicated by a horizontal bar. (***,
p,0.001).
doi:10.1371/journal.pone.0044072.g006
Figure 7. Opposing effects of Rho/Rac pathways in MDV cell-to-cell spread is conserved for two MDV strains. Monolayers of CESCs
were infected or not with one of the two following viruses: (A) the attenuated parental strain BAC20 and (B) the virulent wild-type BAC RB-1B. Six hrs
post-infection, one of the three agents, TAT-C3 transferase, Y-27632 or NSC23766, was added to the cells until the end of the spread assay. The spread
assay lasted 4 days for BAC RB-1B and 3 days for BAC20, due to its fast growth. The graphs show a quantitative analysis of infection plaques size for
each virus in one of two representative experiments (***, p,0.001; **, 0.001,p,0.01; *, 0.01,p,0.05).
doi:10.1371/journal.pone.0044072.g007
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Discussion
The ability of MDV to spread from cell-to-cell is essential for
MDV multiplication in cell culture systems and in its chicken host.
The objective of this work was to examine this process in
relationship with actin filaments and RhoGTPases that regulate
their organization and dynamic as well as actin-associated
structures.
Initially we verified in our cell culture system, enriched in
embryonic skin fibroblasts, the importance of F-actin and actin
dynamic for MDV spread. CytD which prevents actin polymer-
ization led to a drastic reduction of 69% in MDV spread as
reported previously [63]. Jaspl, considered as an actin-stabilizing
toxin in vivo and in vitro also induced a decrease in MDV spread but
less marked (31%). A reduction in cell-to-cell spread was also
observed with Jaspl for PRV in sparsely plated swine testis cells [8].
Both drugs were difficult to handle, as CytD also completely
inhibits cell adhesion at higher concentration and Jaspl prevents
actin depolymerization but also induces actin polymerization [36].
We were indeed able to detect actin aggregates as previously
described for mammalian cells [37]. With respect to Jaspl, the
reduction of MDV spread can be explained in at least three ways.
Firstly, that normal F-actin dynamics contribute to MDV spread.
Secondly, it is conceivable that the observed defect in MDV
spread is associated to the ‘‘indesirable’’ actin polymerizing activity
of Jaspl. Indeed, it can be reasoned that abnormal actin-containing
structures may trap cytoplasmic particles and subsequently reduce
the efficiency of virus egress and spread, a hypothesis hardly
verifiable for MDV. Lastly, Jaspl could also stabilize cortical actin
and makes this barrier more difficult to cross by the virus at the
entry or the exit step.
We showed a role of Rho/Rac signaling pathways on MDV
cell-to-cell spread by using a panel of chemical inhibitors and
purified biological receptor agonists or toxin. Such molecules
could have off-target effects which may also possibly modulate
MDV cell-to-cell spread. Our results obtained with double
treatments (S1P plus IPA-3) indicate that other pathways may
indeed contribute to the MDV spread modulation, but confirmed
that S1P effects on MDV spread is partially mediated through type
I-PAK. Such off-target effects were not detected with LPA on the
Rho-ROCK pathway in our assay. Other results also indicates
that off-targets may not be responsible alone for the MDV spread
modulation observed with the different pharmacological mole-
cules: (i) two ROCK inhibitors produced a comparable MDV
spread reduction, (ii) activators and inhibitors of a cellular target
(either Rho or Rac) gave opposite effects despite acting with
different mechanisms, (iii) all inhibitors targeting proteins involved
at different levels in the Rho pathway led to a similar decrease in
MDV spread, whereas the opposite effects were obtained with Rac
inhibitors. Therefore, although off-targets effects could contribute
to some of the MDV spread modulations observed, especially at
the highest doses (eg. for ROCKs inhibitors), all our results
support a role of Rho/Rac in MDV spread.
Rho/Rac signaling pathways were described to be associated to
the cell-to-cell spread of herpesviruses, like the MHV-68, PRV and
Figure 8. Rho/Rac pathways have opposing effects on the accumulation of N-cadherin at cell-cell contact zones. Typical images of
adherens junctions observed by staining of N-cadherin are shown. Before staining, the CESCs monolayer was left untreated (line A), or treated for
4 days with 16 mg/mL of LPA (line B), 40 mM of Y-27632 (line C) or 40 mM of NSC23766 (line D). DNA was stained with Hoechst 33342 (blue), F-actin
was stained with AlexaFluor594-Phalloidin (red) (column 1) and adherens junctions were stained with an anti-N-cadherin and an AlexaFluor488
secondary antibody (green) (column 2). Bars, 20 mm.
doi:10.1371/journal.pone.0044072.g008
MDV Cell-to-Cell Spread and Rho/Rac Pathways
PLOS ONE | www.plosone.org 11 August 2012 | Volume 7 | Issue 8 | e44072
HSV-1. For these viruses, the reported mechanisms were in
relation to the development of cell extensions containing actin
filaments at late stages of infection. For the MHV-68, fibroblastic
NIH-3T3 cells developed membrane fronds with multibranched
cell extensions 16 hrs pi. This membrane remodeling required the
gp48/ORF58 that promotes intercellular spread and is highly
dependent on RhoA but only moderately dependent on Rac1 [9].
For PRV, infected ST or RK13 cells plated at low density
developed long cellular projections containing actin and microtu-
bules, 4 to 6 hrs pi, and fluorescent capsids can move inside
toward their tips [8]. These cell projections were associated with
US3 protein expression [8] and to be PAK1 dependent, with US3
protein directly phosphorylating group I PAKs [64]. Our data
argue against a model in which MDV does also induce and use
such cellular extensions as a major route for its spread in CESCs.
Firstly, we did not observe an induction of extensive cell
projections by fluorescence microscopy either on cell-sorted
infected CESCs plated at low density [3] or in the periphery of
plaques under normal conditions herein. Secondly, no overex-
pression of MDV viral protein was described to induce the
formation of membrane cell projections including US3 protein in
primary chicken embryo fibroblasts [63]. The fact that in our
study the inhibition of PAK activity did not reduce MDV cell-to-
cell spread but increased it, also argues against a role of group I
PAK-mediated formation of cellular extensions in this process.
Cell-to-cell spread efficiency is the result of the virus cell-to-cell
spread itself and of the virus cycle from the entry to the assembly of
infectious virions, and probably not as a simple sum of virus
release and entry [5]. Since several years, growing evidences show
the role of actin and various RhoGTPases during early and/or late
steps of herpesviruses cycle as thoroughly reviewed
[65,66,67,68,69]. Therefore for MDV, as cell-to-cell spread
cannot be separated from replication, entry and egress need also
to be taken into account in the interpretation of the cell-to-cell
spread results. We are now discussing if one of these steps could
explain the favorable effect of Rho-ROCK pathway and the
negative one of Rac-PAK that we observed in MDV spread. With
respect to entry, for other herpesviruses the involvement of
RhoGTPases was always evaluated a short time post-infection with
cell-free virions at moderate moi, experimental conditions which
are significantly different from ours (infection at low moi with cell-
associated virus, long duration of infection with multiple virus
cycles, on a dense cell layer). Among theses studies, a few depicted
a positive effect of RhoA or ROCKs on the early stages of
infection [70,71,72,73]. For HSV-1, the entry in primary human
corneal fibroblasts and nectin-1-CHO cells was described to
involve RhoA activation and to be mediated by a phagocytosis-like
uptake RhoA-dependent [70]. This process requires, before RhoA
activation, the formation of membrane ruffles which depends on
Rac1 and PAK1 [70,74], a pathway that is not favorable for MDV
cell-to-cell spread. This led us to conclude that a phagocytosis-like
uptake in CESCs cannot explain by itself the effect of Rho/Rac
signaling on MDV spread. Another example is EHV-1 [71], which
enters via an endocytic mechanism or by direct fusion at the cell
surface according to the cells, like HSV-1. In both situations,
EHV-1 requires ROCK activity for a productive EHV-1 infection
through a non-elucidated mechanism, as demonstrated in
presence of Y-27632 or after overexpression of Gem, a negative
ROCK1 regulator. A similar mechanism is therefore possible for
MDV. The last example concerns KSHV, which was found to
activate RhoA early after infection in human fibroblast cells, with
RhoA having a role in the nuclear delivery of viral DNA [72].
Here the role of RhoA was associated to Dia2, another of its
downstream effector [73] and the MTs stabilization, a mechanism
which cannot be excluded at that time for MDV. The role of
RhoGTPases at late stages of infection was poorly studied
compared to entry. Here again, we should consider a positive
role of Rho-ROCK and actomyosin contraction during these
steps, either promoting viral particles intracellular trafficking or
exocytosis of infectious virions. About transport, it is unlikely that
the stress fibers could be used as tracks in the cytoplasm for capsids
movement, as such mechanism was never reported to our
knowledge for long distance movement of viruses. About
exocytosis, it is worthwhile to mention in this context that NMII
was reported as being involved in HSV-1 secretion [75]. However,
this conclusion is based on the interpretation that BDM is a NMII
inhibitor, a property that has been disputed in the literature
[76,77]. Nevertheless, we cannot totally exclude an NMII
contribution to MDV release as NMII was reported to be
involved in constitutive exocytosis and in Ca2+-trigged release of
secretion granules [78]. This hypothesis cannot be tested because
MDV extracellular virions are not detectable in cell culture.
Therefore at this stage, a promoting role of Rho-ROCK during
entry and/or of NMII activity during the late stages, although not
testable, are possible mechanistic hypotheses.
In this study, we demonstrate an opposing influence of Rho/
Rac pathways on MDV cell-to-cell spread with Rho-ROCK
signaling positively regulating it. Whether MDV infection directly
activates Rho and/or suppresses Rac signaling or whether the
MDV has just benefited from the physiological Rho/Rac balance
already present in non-infected cells for its replication and spread
has not been assessed. Indeed two limitations combine to address
this question: (i) only a fraction of the cells are infected and from
various time and (ii) only a small fraction of the total Rho pool is
activated at the same time in a cell (5%) [79]. Therefore,
answering to this question will be very difficult for MDV in
absence of cell-free inoculum to truly synchronized infection and
performed it at moderate moi at a define post-infection time point.
The first hypothesis, that MDV infection modifies Rho/Rac
signaling at one step of its virus cycle, is likely as many
herpesviruses do so [65,69], even if the absence of pronounced
cell morphology changes and actin cytoskeleton reorganization in
infection plaque periphery, assumed to contain the more recently
infected cells, does not suggest so. Nevertheless, these changes
could be to short in time to be noticeable without synchronization
of infection. The second hypothesis, that MDV just exploits the
physiological Rho-ROCK activity for its replication and spread
must be considered and cannot be ruled out. Indeed, our non-
infected cell cultures exhibit a typical Rho phenotype with large
number of stress fibers and focal adhesions plaques (not shown).
Here we collected data supporting a model in which stress fiber
maintenance associated to cell shape and cell-cell junction
persistence between infected and non-infected cells is critical for
MDV cell-to-cell spread. Firstly, we observed that stress fibers are
still present in infected cells at the periphery of the viral plaque.
Prima facie, the persistence of stress fibers in infected cells was
surprising as the virus encodes a US3 protein described to
breakdown stress fibers. However, this feature was observed only
in less than 70% of infected cells [63], an observation that is in
good agreement with our own data. Moreover, with a US3 deleted
MDV, stress fibers breakdown was still observed in 50% of the
infected cells [63]. Taken together these observations suggest that
the stress fibers disappearance in MDV infected cells is only
partially due to US3 protein and is possibly more a reflection of
the cytopathogenic effect. Secondly, we have shown that under
conditions favoring stress fiber preservation and elongated shape,
the plaque morphology was linked to the semi-ordered arrange-
ment of the cell in the plaque microenvironment. In contrast,
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when stress fibers formation was inhibited and elongated shape
was lost, the plaque morphology was altered towards a more
circular and smaller appearance. This suggests that stress fibers
possibly in association with cell shape could influence the direction
of viral spread and contribute to its efficiency. In addition, a
possible role of the Golgi may be evocated. Indeed, when cells are
cultivated on substrate with extracellular matrix micropatterns,
intracellular trafficking out of the Golgi is oriented toward cell
adhesive regions [80]. As adhesive structures are developed at the
extremities of elongated cells, an oriented virions exocytosis
through the Golgi apparatus in our cells cannot be totally ruled-
out. Thirdly, under normal conditions, we also noticed at the
periphery of the plaques that cell-cell junctions were visible
between infected and non-infected cells with intercellular junctions
enriched in actin cables reminiscent of AJs. Fourth and lastly, we
demonstrated that MDV cell-to-cell spread was modulated in
similar way by Rho/Rac manipulation than AJs stabilization and
maintenance in non-infected cells. Indeed, under MDV cell-to-cell
spread-compromising conditions, as upon treatment with Y-
27632, the AJs were barely visible using an N-cadherin marker.
In contrast, under conditions that are favorable for MDV spread,
as upon treatment with LPA or NSC23766, the AJs were more
readily detectable than in non-treated controls. This finding is in
perfect line with the important role of Rho signaling in the
formation and/or maintenance of AJs in mammalian myoblasts or
fibroblasts [24,59,60]. For example, in C2C12 mouse myoblasts,
Rac1 and RhoA were found to exert opposite effects, with RhoA
promoting N-cadherin dependent cell-cell contacts. In addition,
ROCK signaling and myosin II activation were found to stabilize
N-cadherin at the cell-cell contact sites [59].
In conclusion, we showed for the first time that Rho/Rac
pathways regulate MDV cell-to-cell spread. In particular, we
found that Rho-ROCK pathway and actomyosin contraction is
beneficial for MDV spread while Rac-PAK is detrimental. We also
showed that the stabilization and maintenance of AJs, the only
cell-cell junctions found to date in fibroblastic cells, are affected in
a similar way by RhoGTPases manipulations than MDV cell-to-
cell spread. Considering the cell-cell transmission of MDV, the
importance of AJs or AJs proteins in alpha-herpesviruses entry or
egress [10,18,81] and the rarity of cell extensions in our virus/cell
system, we hypothesize that these junctions could be of special
interest in MDV biology. In the future, our efforts will focus on
deciphering a direct role of AJs in MDV cell-to-cell spread and to
examine if MDV virions could be routed via this cell-cell contact.
Materials and Methods
Cells and viruses
Chicken embryo skin cells (CESCs) were prepared from 12 day-
old, specific-free-pathogen Brown Leghorn (LD1) embryos exactly
as previously described [82]. CESCs were cultivated at 41uC in
William’s E media (Lonza, Basel, Switzerland) supplemented with
2 mM of L-Glutamine (Lonza), 1% of fetal calf serum, 1.5% of
chicken serum plus 5 mM of N,N9-Hexamethylene bisacetamide
(HMBA) at confluency including during infection. At explantation,
the monolayers contained mostly fibroblasts, a low percentage of
myoblasts, for which the differentiation into myotubes was
inhibited by HMBA [83], and rare keratinocytes. These cell types
were identified on the basis of morphology and immunochemistry
with a few cellular markers (N-Cadherin, Vimentin, integrin ß-1,
Pax7 and Cytokeratin). Two BAC-derived MDV strains were used
in this study: the highly virulent BAC RB-1B strain repaired for
UL13, UL44 (gC), US2 and US6 (gD) [58,84], and the attenuated
strain BAC20 [85]. One mutant virus generated from the BAC20
was used: the BAC20-EGFPVP22 (named herein BAC20-EGFP),
which expresses the enhanced green fluorescent protein N-
terminally fused to the viral VP22 tegument protein [34]. The
sorted BAC20-EGFP-infected cells were obtained by flow
cytometry on a MoFlo (DakoCytomation) with a purity above
95% as previously described [3].
Pharmacological agents
Stock solutions were made in dimethyl sulfoxide (DMSO) for:
cytochalasin D (CytD) (C8273, Sigma) at 20 mM, jasplakinolide
(Jaspl) (J7473, Invitrogen) at 1 mM, IPA-3 (cat#506106, Calbio-
chem) at 20 mM, blebbistatin (Bleb) (B0560, Sigma) at 25 mM.
The maximal final concentration of DMSO used in this study did
not exceed 0.1%. Sphingosine-1-phosphate (S1P) (S9666, Sigma)
at 1 mM, NSC23766 (National Cancer Institute) at 50 mM, L-
alpha-lysophosphatidic acid, oleyl, sodium (LPA) (l7260, Sigma) at
1 mg/mL, Y-27632 (cat#688000, Calbiochem) at 5 mM and
Fasudil, monohydrochloride salt (F-4660, LClabs) at 30 mM were
dissolved in H2O as stock solutions.
Purification of TAT-C3 transferase
The C3 transferase is a toxin from Clostridium botulinum, which
was fused to a (His)6- and a HIV-1 TAT-tag at its N-terminus [86].
The expression in bacteria and purification of the TAT-C3
transferase has been described previously [87]. The purity of the
protein was controlled by migration on a 12% SDS-PAGE
followed by a Coomassie staining of the gel. The protein
concentration was subsequently determined using the quick start
Bradford Protein Assay (500-0203, Biorad). Before addition in
CESCs culture media, TAT-C3 transferase was dialyzed overnight
at 4uC against PBS (Slide-A-LyzerH Dialysis Cassettes, Pierce), in
order to eliminate the elution buffer containing imidazole at a
concentration of 250 mM. Finally, the protein activity was
controlled on non-confluent CESCs for its effect on actin
organization.
Immunofluorescence microscopy
Cells treated with drugs or purified TAT-C3 transferase were
cultivated directly on 0.17 mm glass coverslips coated with 0.17%
gelatin. Cells were fixed with 4% paraformaldehyde (PFA) for
30 min at room temperature, permeabilized and blocked with
PBS, 0.1% Triton X-100, 0.5% BSA. F-actin was stained with
AlexaFluor594-Phalloidin (1:200) (A12381, Molecular Probes) and
nuclei with Hoechst 33342 (1:2,000) (H-3570, Molecular Probes).
For AJs staining, cells were fixed with 4% PFA in the presence of
0.1% Triton, and the anti-N-cadherin mouse monoclonal
antibody (1:200) (GC-4, Sigma) was used and an AlexaFluor488
secondary antibody (A11001, Invitrogen). Cells were observed on
an Axiovert 200 M inverted epi-fluorescence microscope equipped
with a 406 PlanNeofluar oil/Dic objective or a 636 PlanApo-
chromat oil/DIC, both with the ApoTome system (Zeiss). Images
were captured with a CCD Axiocam MRm camera (Zeiss) using
the Axiovision software (Zeiss).
MDV cell-to-cell spread assays
The basic assay was as follows: approximately 106 CESCs,
plated in 3.5 cm diameter-wells (9.6 cm2), corresponding to a
confluent monolayer, were infected by coculture with 3.26103
GFP-positive-sorted BAC20-EGFP-infected cells. After 6 hrs of
infection, a pharmacological agent was added at different
concentrations to the culture medium, and the cells were further
incubated for 90 hrs. The drugs containing media were renewed
at 48 hrs post-infection. For dialyzed TAT-C3 transferase protein,
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the assay was performed on 1.6 cm diameter plate (2 cm2) and the
protein was renewed once at 30 hrs post-infection. In these cell
culture formats, for unkown reasons, plaques sizes were repro-
ducibly smaller than in larger plates (.9.6 cm2). After the 4-day
incubation period, cells were fixed by 4% PFA. Plaques were
detected with a Fluar65 objective or a 56EC plan-neofluar/ph1
mounted on an inversed Axiovert 200 M inverted epi-fluorescence
microscope (Zeiss). Plaques size measurements were performed on
images captured from 50 plaques through a CCD Axiocam MRm
camera using the Axiovision software (Zeiss) as previously
described [34]. Plaque areas were measured with Axiovision
software with the outline measure tool, by manually drawing the
outline of each plaque. When the outline was closed, the surface
area was automatically calculated in mm2. Plaque sizes after drug
treatment were averaged over 50 plaques using Prism 5.0 software
(GraphPad Prism software version 5.01), and mean plaque sizes
for each experiment was analyzed using the Kruskal-Wallis test.
When significant differences were detected, a Dunn test was used
to compare each condition with the control. Plaque size
measurements after each drug treatment was performed in two
to three independent experiments. As the plaques size may varies
for a same virus according to the cell density, an internal control
was introduced in each independent experiment and the various
conditions compared to it.
When the BAC20 virus was used, the duration of spread was
reduced to 3 days as this virus grows faster and leads to higher
plaques sizes on cell monolayer than BAC20-EGFP and the BAC
RB-1B. When a cell monolayer was infected with a non-
fluorescent MDV as the BAC20 or the BAC RB-1B, infection
plaques were revealed by staining with a cocktail of three mouse
monoclonal antibodies (F19 anti-VP5, K11 anti-gB, and E21 anti-
ICP4; each diluted at 1:1,000) followed by a goat anti-mouse
AlexaFluorH 488 (Invitrogen, Carlsbad, CA, USA) as described
[88]. Next, plaques sizes were measured on the basis of the green
fluorescence as described above.
To study differences in plaques shape between several
conditions, the following analysis was performed: after having
outlined the plaque areas, a first segment between the two most
distant points of the outline was measured with Axiovision
software and defined as length. A second segment, perpendicular
to the first and crossing it in its mid was outlined and measured,
and defined as width. For 30 plaques, the ratio between plaque
length on plaque width was next calculated and plotted on a
graph. Statistical analyses were performed as described above.
Cell viability assay
Uninfected CESCs were cultivated in 24-well plates in the
presence of the highest concentration of drugs or TAT-C3
transferase protein using the same conditions as described for the
MDV cell-to-cell spread assay but without MDV infection. After a
4-day treatment, the AlamarBlue viability reagent (DAL1025,
Invitrogen) was added into the cell culture media, according to the
manufacturer’s recommendations. After 3 hrs, the cell viability
was determined by monitoring the substrate fluorescence with a
Spectramax Gemini EM spectrofluorimeter and with the Soft-
MaxPro software (Molecular Devices). Results were reported as
the ratio between the fluorescence units measured for the treated
cells and non-treated cells. For each drug, this assay was
performed at least in two independent experiments and in
triplicate. For each condition, the SEM was calculated. We set
the threshold of cell viability acceptable for our cell-to-cell spread
assay at 75% of the mock-treated cells. This threshold corresponds
to the cell viability measured for the treatment with the NSC23766
at 40 mM, and for which we observed an increase of cell-to-cell
MDV spread.
Gel electrophoresis and immunoblotting to detect the
phosphorylation of myosin light chain (MLC)
Cells cultivated in 6 cm diameter-dishes, treated or not with Y-
27632 or Fasudil, were rinsed once in PBS and directly lyzed in
electrophoresis sample buffer 26 containing 120 mM Tris-HCl
(pH 6.8), 20% glycerol (vol/vol), 4% SDS, 2.5% ß-mercaptoeth-
anol, 2 mM EGTA, 0.01% Bromophenol blue. Lysates were
boiled for 3 minutes, separated on 12% SDS-PAGE, transferred
onto a nitrocellulose membrane (cat#741290 Porablot NCL,
Macherey-Nagel) through a semi-dry system and blotted as follow.
The membrane was incubated either with a mouse monoclonal
anti-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) anti-
body (1:500) (cat#MAB374, Chemicon-Millipore) or a rabbit anti-
Phospho-Myosin Light Chain (Thr18/Ser19) (1:1000) (cat#3674,
Cell Signaling) overnight at 4uC and an alkaline phosphatase-
conjugated secondary antibody. The alkaline phosphatase was
detected with a solution made of nitro Blue tetrazolium chloride
(NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP)
(Zymed).
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